Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
Oliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung
Department of Neurology, Heinrich Heine University, Moorenstrasse 5, D 40225 Düsseldorf, Germany. oliver.neuhaus@uni-duesseldorf.de
Expert review of neurotherapeutics 2004 JanThe conclusions of a recent study of mitoxantrone (Novantrone) in multiple sclerosis and the approval of several health authorities support its use in patients with active relapsing-remitting or secondary progressive multiple sclerosis. This drug profile provides an outline on relevant preclinical and clinical studies, discusses relevant side effects of the compound and places mitoxantrone in the context of other therapeutic approaches available against this disabling disorder.
Citation
Oliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung. Mitoxantrone (Novantrone) in multiple sclerosis: new insights. Expert review of neurotherapeutics. 2004 Jan;4(1):17-26
Mesh Tags
Substances
PMID: 15853611
View Full Text
